GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » EV-to-FCF

3B BlackBio Dx (BOM:532067) EV-to-FCF : (As of May. 16, 2024)


View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, 3B BlackBio Dx's Enterprise Value is ₹6,267.2 Mil. 3B BlackBio Dx's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.0 Mil. Therefore, 3B BlackBio Dx's EV-to-FCF for today is .

The historical rank and industry rank for 3B BlackBio Dx's EV-to-FCF or its related term are showing as below:

BOM:532067' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 33.87
Current: 26.25

During the past 13 years, the highest EV-to-FCF of 3B BlackBio Dx was 33.87. The lowest was 0.00. And the median was 0.00.

BOM:532067's EV-to-FCF is ranked worse than
67.45% of 381 companies
in the Biotechnology industry
Industry Median: 7.56 vs BOM:532067: 26.25

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), 3B BlackBio Dx's stock price is ₹798.35. 3B BlackBio Dx's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹38.779. Therefore, 3B BlackBio Dx's PE Ratio for today is 20.59.


3B BlackBio Dx EV-to-FCF Historical Data

The historical data trend for 3B BlackBio Dx's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx EV-to-FCF Chart

3B BlackBio Dx Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.08 7.82 2.07 7.14 13.43

3B BlackBio Dx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 13.43 - - -

Competitive Comparison of 3B BlackBio Dx's EV-to-FCF

For the Biotechnology subindustry, 3B BlackBio Dx's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3B BlackBio Dx's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's EV-to-FCF falls into.



3B BlackBio Dx EV-to-FCF Calculation

3B BlackBio Dx's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6267.174/0
=

3B BlackBio Dx's current Enterprise Value is ₹6,267.2 Mil.
3B BlackBio Dx's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3B BlackBio Dx  (BOM:532067) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

3B BlackBio Dx's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=798.35/38.779
=20.59

3B BlackBio Dx's share price for today is ₹798.35.
3B BlackBio Dx's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹38.779.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


3B BlackBio Dx EV-to-FCF Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


3B BlackBio Dx (BOM:532067) Business Description

Traded in Other Exchanges
N/A
Address
7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines